Personalis to Participate at Upcoming Investor Conferences
Personalis, a leader in advanced genomics for precision oncology, has announced its participation in two upcoming investor conferences. The company's management team will be present at the Morgan Stanley 22nd Annual Global Healthcare Conference on September 5, 2024, where they will give a presentation at 4:50 pm Eastern Time at the Marriott Marquis in New York. Additionally, Personalis will attend the Lake Street 8th Annual Best Ideas Growth (BIG) Conference on September 12, 2024, at the Yale Club in New York.
These conferences provide Personalis with opportunities to showcase their advancements in genomics and precision oncology to potential investors and industry professionals. The company's participation in such events demonstrates its commitment to engaging with the investment community and sharing its vision for the future of personalized cancer care.
Personalis, un leader nella genomica avanzata per l'oncologia di precisione, ha annunciato la sua partecipazione a due prossimi convegni per investitori. Il team di gestione dell'azienda sarà presente al 22° Convegno Sanitario Globale Annuale di Morgan Stanley il 5 settembre 2024, dove presenteranno alle 16:50 ora orientale presso il Marriott Marquis a New York. Inoltre, Personalis parteciperà al 8° Convegno Annuale delle Migliori Idee di Crescita (BIG) di Lake Street il 12 settembre 2024, presso il Yale Club a New York.
Questi convegni offrono a Personalis l'opportunità di mostrare i propri progressi nella genomica e nell'oncologia di precisione a potenziali investitori e professionisti del settore. La partecipazione dell'azienda a tali eventi dimostra il suo impegno a interagire con la comunità degli investimenti e a condividere la sua visione per il futuro della cura personalizzata del cancro.
Personalis, un líder en genómica avanzada para la oncología de precisión, ha anunciado su participación en dos próximas conferencias para inversores. El equipo directivo de la empresa estará presente en la 22ª Conferencia Global Anual de Atención Médica de Morgan Stanley el 5 de septiembre de 2024, donde ofrecerán una presentación a las 4:50 p.m. hora del Este en el Marriott Marquis de Nueva York. Además, Personalis asistirá a la 8ª Conferencia Anual de Mejores Ideas de Crecimiento (BIG) de Lake Street el 12 de septiembre de 2024, en el Yale Club de Nueva York.
Estas conferencias ofrecen a Personalis oportunidades para mostrar sus avances en genómica y oncología de precisión a posibles inversores y profesionales de la industria. La participación de la empresa en estos eventos demuestra su compromiso de interactuar con la comunidad inversora y compartir su visión para el futuro de la atención personalizada del cáncer.
Personalis는 정밀 종양학을 위한 고급 유전체학의 선두 주자로서 두 개의 다가오는 투자자 회의에 참여할 것이라고 발표했습니다. 회사의 경영진 팀은 2024년 9월 5일 모건 스탠리 제22회 전 세계 헬스케어 회의에 참석할 예정이며, 뉴욕의 메리어트 마르퀴스에서 동부 시간으로 오후 4시 50분에 발표를 진행할 것입니다. 또한 Personalis는 2024년 9월 12일 레이크 스트리트 제8회 연례 베스트 아이디어 성장(BIG) 회의에 참석할 예정입니다. 이는 뉴욕의 예일 클럽에서 열립니다.
이 회의는 Personalis가 잠재적인 투자자와 산업 전문가에게 유전체학 및 정밀 종양학의 발전을 선보일 수 있는 기회를 제공합니다. 이러한 행사에 참여하는 것은 회사의 투자 커뮤니티와의 소통 및 개인화된 암 치료의 미래에 대한 비전을 공유하겠다는 의지를 보여줍니다.
Personalis, un leader dans la génomique avancée pour l'oncologie de précision, a annoncé sa participation à deux prochaines conférences pour investisseurs. L'équipe de direction de l'entreprise sera présente à la 22ème Conférence Annuelle Mondiale sur la Santé de Morgan Stanley le 5 septembre 2024, où elle fera une présentation à 16h50, heure de l'Est, au Marriott Marquis à New York. De plus, Personalis assistera à la 8ème Conférence Annuelle des Meilleures Idées de Croissance (BIG) de Lake Street le 12 septembre 2024, au Yale Club à New York.
Ces conférences offrent à Personalis des occasions de présenter ses avancées en génomique et en oncologie de précision à des investisseurs potentiels et à des professionnels de l'industrie. La participation de l'entreprise à ces événements démontre son engagement à interagir avec la communauté d'investissement et à partager sa vision pour l'avenir des soins personnalisés contre le cancer.
Personalis, ein führendes Unternehmen im Bereich der fortschrittlichen Genomik für präzise Onkologie, hat seine Teilnahme an zwei bevorstehenden Investorenkonferenzen angekündigt. Das Managementteam des Unternehmens wird am 5. September 2024 auf der 22. jährlichen globalen Gesundheitskonferenz von Morgan Stanley anwesend sein, wo sie um 16:50 Uhr Eastern Time im Marriott Marquis in New York eine Präsentation halten werden. Zusätzlich wird Personalis am 12. September 2024 an der 8. jährlichen Best Ideas Growth (BIG)-Konferenz von Lake Street im Yale Club in New York teilnehmen.
Diese Konferenzen bieten Personalis die Möglichkeit, ihre Fortschritte in der Genomik und präzisen Onkologie potenziellen Investoren und Fachleuten der Branche vorzustellen. Die Teilnahme des Unternehmens an solchen Veranstaltungen demonstriert sein Engagement, mit der Investmentgemeinschaft in Kontakt zu treten und seine Vision für die Zukunft der personalisierten Krebsbehandlung zu teilen.
- None.
- None.
-
Morgan Stanley 22nd Annual Global Healthcare Conference
Date: Thursday, September 5, 2024
Presentation Time: 4:50 pm Eastern Time
Location: Marriott Marquis inNew York
-
Lake Street 8th Annual Best Ideas Growth (BIG) Conference
Date: Thursday, September 12, 2024
Location: Yale Club inNew York
About Personalis, Inc.
At Personalis, we are transforming the active management of cancer through breakthrough personalized testing. We aim to drive a new paradigm for cancer management, guiding care from biopsy through the life of the patient. Our highly sensitive assays combine tumor-and-normal profiling with proprietary algorithms to deliver advanced insights even as cancer evolves over time. Our products are designed to detect minimal residual disease (MRD) and recurrence at the earliest time points, enable the selection of targeted therapies based on ultra-comprehensive genomic profiling, and enhance biomarker strategy for drug development. Personalis is based in
View source version on businesswire.com: https://www.businesswire.com/news/home/20240822337911/en/
Investors:
Caroline Corner
investors@personalis.com
415-202-5678
Media:
pr@personalis.com
Source: Personalis, Inc.
FAQ
When and where is Personalis (PSNL) presenting at the Morgan Stanley Global Healthcare Conference in 2024?
Which investor conferences is Personalis (PSNL) attending in September 2024?
What is the location of the Lake Street Best Ideas Growth Conference that Personalis (PSNL) is attending?
How does Personalis (PSNL) describe its business focus in the press release?
